450
Participants
Start Date
October 15, 2019
Primary Completion Date
September 30, 2026
Study Completion Date
March 31, 2027
Vancomycin
Patients randomized into the treatment arm will receive 1-2 g of vancomycin powder (Vancocin® i.v.) which will be administered above the closed muscle fascia (suprafascially) before closing the subcutaneous tissue and skin. The dose of the drug will depend on the length of the skin incision: 1 g for incisions ≤ 20 cm, 2 g for incisions ≥ 20 cm.
Spitalzentrum Biel, Biel
University Hostpital Bern, Department of Neurosurgery, Bern
University Hostpital Bern, Department of orthopaedy, Bern
Lindenhofspital Bern, Bern
Klinik St. Anna, Lucerne
University Hospital Zurich, Department of Neurosurgery, Zurich
Kantonsspital St. Gallen, Sankt Gallen
University Hospital Freiburg
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER